BIO-RAD LABORATORIES-A (BIO)
US0905722072 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.923B 14.81% | 2.802B -4.12% | 2.671B -4.67% | 2.605B -2.48% | 2.681B 2.92% | 2.811B 4.85% | 2.922B 3.95% | 3.039B 4.00% | |
| EBITDA YoY % growth | N/A 41.54% | N/A -13.40% | N/A -19.14% | 476.49M -8.26% | 525.47M 10.28% | 575.9M 9.60% | 618.12M 7.33% | 665.59M 7.68% | |
| EBIT YoY % growth | 564.7M 34.04% | 486.8M -13.79% | 365.696M -24.88% | 342.05M -6.47% | 389.41M 13.85% | 432.2M 10.99% | 489.85M 13.34% | 531.26M 8.45% | |
| Operating Margin | 19.32% | 17.37% | 13.69% | 13.13% | 14.52% | 15.38% | 16.76% | 17.48% | |
| EPS YoY % growth | 15.67 48.81% | 14.23 -9.19% | 11.77 -17.29% | 10.39 -11.73% | 11.63 11.93% | 13.21 13.63% | 12.53 -5.14% | 13.51 7.82% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 2.89 -6.75% | 2.68 17.19% | 3.04 -2.13% | 2.94 46.11% | 3.10 7.13% | 2.84 5.76% | 3.10 1.87% | 3.31 12.80% | 3.62 16.76% |
| Revenue Q2Q % growth | 688.11M 1.02% | 637.03M 4.29% | 668.97M 4.78% | 679.53M 4.59% | 713.87M 3.74% | 650.23M 2.07% | 683.37M 2.15% | 695.83M 2.40% | 733.31M 2.72% |
| EBITDA Q2Q % growth | 134.48M -2.07% | 117M 23.43% | 135.74M 33.55% | 135.38M 88.10% | 140.99M 4.84% | 110.35M -5.68% | 137.43M 1.25% | 144.96M 7.08% | 155.41M 10.23% |
| EBIT Q2Q % growth | 100.28M 2.94% | 80.857M 56.07% | 103.07M 2.97% | 102.09M 8.65% | 107.25M 6.95% | 76.73M -5.10% | 103.53M 0.45% | 110.29M 8.03% | 119.9M 11.79% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 2.01 -13.73% | 1.17 | 0.84 | 72.05% |
| Q2 2024 Q2Q % growth | 3.11 3.67% | 2.03 | 1.08 | 52.84% |
| Q1 2024 Q2Q % growth | 2.29 -31.44% | 2.17 | 0.12 | 5.67% |
| Q4 2023 Q2Q % growth | 3.10 -6.34% | 2.85 | 0.25 | 8.96% |
| Q3 2023 Q2Q % growth | 2.33 -10.38% | 2.81 | -0.48 | -17.09% |
| Q2 2023 Q2Q % growth | 3.00 -11.24% | 2.71 | 0.29 | 10.88% |
| Q1 2023 Q2Q % growth | 3.34 -32.39% | 3.58 | -0.24 | -6.64% |
| Q4 2022 Q2Q % growth | 3.31 3.12% | 3.48 | -0.17 | -4.96% |
| Q3 2022 Q2Q % growth | 2.60 -29.92% | 2.81 | -0.21 | -7.47% |
| Q2 2022 Q2Q % growth | 3.38 -4.52% | 2.83 | 0.55 | 19.58% |
| Q1 2022 Q2Q % growth | 4.94 -5.18% | 3.44 | 1.50 | 43.76% |
| Q4 2021 Q2Q % growth | 3.21 -19.95% | 2.88 | 0.33 | 11.49% |
| Q3 2021 Q2Q % growth | 3.71 23.67% | 2.46 | 1.25 | 50.71% |
| Q2 2021 Q2Q % growth | 3.54 119.88% | 2.69 | 0.85 | 31.54% |
| Q1 2021 Q2Q % growth | 5.21 172.77% | 3.03 | 2.18 | 72.12% |
| Q4 2020 Q2Q % growth | 4.01 72.84% | 3.33 | 0.68 | 20.49% |
| Q3 2020 Q2Q % growth | 3.00 86.34% | 1.82 | 1.18 | 64.86% |
| Q2 2020 Q2Q % growth | 1.61 8.05% | 1.24 | 0.37 | 30.31% |
| Q1 2020 Q2Q % growth | 1.91 15.76% | 1.58 | 0.33 | 20.84% |
| Q4 2019 Q2Q % growth | 2.32 8.92% | 2.47 | -0.15 | -6.05% |
| Q3 2019 Q2Q % growth | 1.61 76.92% | 1.42 | 0.19 | 13.46% |
| Q2 2019 Q2Q % growth | 1.49 -9.15% | 1.35 | 0.14 | 10.51% |
| Q1 2019 Q2Q % growth | 1.65 41.03% | 1.12 | 0.53 | 47.84% |
| Q4 2018 Q2Q % growth | 2.13 | 1.72 | 0.41 | 23.87% |
| Q3 2018 Q2Q % growth | 0.91 | 1.16 | -0.25 | -21.31% |
| Q2 2018 Q2Q % growth | 1.64 | 1.28 | 0.36 | 27.86% |
| Q1 2018 Q2Q % growth | 1.17 | 1.08 | 0.09 | 8.26% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 649.729M 2.79% | 634.46M | 15.269M | 2.41% |
| Q2 2024 Q2Q % growth | 638.476M -6.26% | 652.25M | -13.774M | -2.11% |
| Q1 2024 Q2Q % growth | 610.82M -9.75% | 625.28M | -14.46M | -2.31% |
| Q4 2023 Q2Q % growth | 681.184M -6.73% | 691.94M | -10.756M | -1.55% |
| Q3 2023 Q2Q % growth | 632.1M -7.15% | 696.46M | -64.36M | -9.24% |
| Q2 2023 Q2Q % growth | 681.11M -1.45% | 704.94M | -23.83M | -3.38% |
| Q1 2023 Q2Q % growth | 676.844M -3.32% | 696.73M | -19.886M | -2.85% |
| Q4 2022 Q2Q % growth | 730.3M -0.34% | 749.67M | -19.37M | -2.58% |
| Q3 2022 Q2Q % growth | 680.8M -8.86% | 686.74M | -5.94M | -0.86% |
| Q2 2022 Q2Q % growth | 691.1M -3.46% | 689.45M | 1.65M | 0.24% |
| Q1 2022 Q2Q % growth | 700.1M -3.67% | 681.85M | 18.25M | 2.68% |
| Q4 2021 Q2Q % growth | 732.8M -7.22% | 739.3M | -6.5M | -0.88% |
| Q3 2021 Q2Q % growth | 747M 15.40% | 668.49M | 78.51M | 11.74% |
| Q2 2021 Q2Q % growth | 715.9M 33.34% | 638.1M | 77.8M | 12.19% |
| Q1 2021 Q2Q % growth | 726.8M 27.15% | 667.59M | 59.21M | 8.87% |
| Q4 2020 Q2Q % growth | 789.8M 26.49% | 693.67M | 96.13M | 13.86% |
| Q3 2020 Q2Q % growth | 647.3M 15.47% | 576.28M | 71.02M | 12.32% |
| Q2 2020 Q2Q % growth | 536.9M -6.23% | 522.22M | 14.68M | 2.81% |
| Q1 2020 Q2Q % growth | 571.6M 3.18% | 552.32M | 19.28M | 3.49% |
| Q4 2019 Q2Q % growth | 624.4M 1.23% | 648.37M | -23.97M | -3.70% |
| Q3 2019 Q2Q % growth | 560.6M 2.84% | 570.69M | -10.09M | -1.77% |
| Q2 2019 Q2Q % growth | 572.6M -0.57% | 571.86M | 740K | 0.13% |
| Q1 2019 Q2Q % growth | 554M 0.45% | 555.05M | -1.05M | -0.19% |
| Q4 2018 Q2Q % growth | 616.8M | 615.11M | 1.69M | 0.27% |
| Q3 2018 Q2Q % growth | 545.1M | 544.07M | 1.03M | 0.19% |
| Q2 2018 Q2Q % growth | 575.9M | 553.92M | 21.98M | 3.97% |
| Q1 2018 Q2Q % growth | 551.5M | 532.47M | 19.03M | 3.57% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -15.83% | 0% | 7.4% |
| Revenue | 0% | -6.96% | 0% | 0.08% |